Overview
MT-ATP6-related mitochondrial spastic paraplegia is a very rare genetic condition that affects the nervous system, specifically the nerves that control leg movement. It is caused by changes (mutations) in the MT-ATP6 gene, which is found in mitochondrial DNA — the energy-producing structures inside every cell of your body. When this gene does not work properly, cells in the brain and spinal cord that require a lot of energy cannot function normally, leading to progressive stiffness and weakness in the legs, known as spastic paraplegia. The hallmark symptom is gradually increasing stiffness (spasticity) in the lower limbs, which makes walking difficult over time. Some patients may also experience other neurological problems such as balance difficulties, fatigue, and sometimes mild cognitive changes, depending on the severity of the mitochondrial dysfunction. Because mitochondria are present in nearly every cell, some individuals may have additional symptoms affecting other organ systems, though the legs are most prominently affected. There is currently no cure for this condition. Treatment focuses on managing symptoms and maintaining quality of life. Physical therapy, medications to reduce muscle stiffness (such as baclofen or tizanidine), and assistive devices like braces or walkers can help with mobility. Because this is a mitochondrial disorder, some doctors may also recommend supplements such as coenzyme Q10 or L-carnitine to support mitochondrial function, although strong evidence for their effectiveness in this specific condition is limited. Regular follow-up with a neurologist and a geneticist experienced in mitochondrial diseases is important.
Key symptoms:
Stiffness in the legs (spasticity)Difficulty walkingLeg weaknessBalance problemsIncreased muscle tone in the lower limbsFatigue and low energyExaggerated reflexes in the legsFoot deformities such as high archesBladder control problemsNumbness or tingling in the feetDifficulty with coordinationMuscle cramps in the legs
Clinical phenotype terms (17)— hover any for plain English
Mitochondrial
Passed from mother to child through the energy-producing parts of the cell
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for MT-ATP6-related mitochondrial spastic paraplegia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for MT-ATP6-related mitochondrial spastic paraplegia at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for MT-ATP6-related mitochondrial spastic paraplegia.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to MT-ATP6-related mitochondrial spastic paraplegia.
Community
No community posts yet. Be the first to share your experience with MT-ATP6-related mitochondrial spastic paraplegia.
Start the conversation →Latest news about MT-ATP6-related mitochondrial spastic paraplegia
No recent news articles for MT-ATP6-related mitochondrial spastic paraplegia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is my heteroplasmy level, and how does it affect my expected disease course?,What physical therapy program would be most helpful for maintaining my mobility?,Are there any mitochondrial supplements you recommend, and what evidence supports them?,How often should I have follow-up neurological evaluations?,Are there any clinical trials or new treatments being studied for MT-ATP6 mutations?,Should my family members be tested for this mitochondrial mutation?,What should I do if my symptoms suddenly get worse, such as during an illness?
Common questions about MT-ATP6-related mitochondrial spastic paraplegia
What is MT-ATP6-related mitochondrial spastic paraplegia?
MT-ATP6-related mitochondrial spastic paraplegia is a very rare genetic condition that affects the nervous system, specifically the nerves that control leg movement. It is caused by changes (mutations) in the MT-ATP6 gene, which is found in mitochondrial DNA — the energy-producing structures inside every cell of your body. When this gene does not work properly, cells in the brain and spinal cord that require a lot of energy cannot function normally, leading to progressive stiffness and weakness in the legs, known as spastic paraplegia. The hallmark symptom is gradually increasing stiffness (s
How is MT-ATP6-related mitochondrial spastic paraplegia inherited?
MT-ATP6-related mitochondrial spastic paraplegia follows a mitochondrial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.